Chembio Diagnostics Inc (CEMI.OQ)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|58||2014||Non-Executive Independent Chairman of the Board|
|52||2017||President, Chief Executive Officer, Director|
|58||2004||Chief Financial Officer|
|49||2017||President - Americas Region|
|48||2015||Chief Science and Technology Officer|
- BRIEF-Chembio receives $8.5 mln commitment from Bio-Manguinhos to purchase components for production of dpp Assays in Brazil during 2018
- BRIEF-Chembio Diagnostics Awarded UNICEF Contract
- BRIEF-Chembio Diagnostics posts Q3 loss of $0.05 per share
- BRIEF-Chembio Diagnostics CEO has returned to work after a medical leave of absence
- BRIEF-Chembio Diagnostics receives FDA emergency use authorization for the first rapid Zika Igm test